Active, Not Recruiting
Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
NCT03712202
- Conditions
- Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Lymphocyte-Depleted Classic HL, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, +20 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- City of Hope Medical Center Duarte, California, United States
- University of California San Diego San Diego, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States